Report Detail
Global (United States, European Union and China) Genital Herpes Treatment Market Research Report 2019-2025
- RnM3641538 |
- 02 August, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Zovirax is the main brand available in the market for genital herpes. It can also treat chickenpox.
Among these drug types prevalent in the genital herpes treatment, Acyclovir segment dominated the global genital herpes treatment market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
In 2019, the market size of Genital Herpes Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Genital Herpes Treatment.
This report studies the global market size of Genital Herpes Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Genital Herpes Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Teva
Abbott
Sun
Mylan
Pfizer
GlaxoSmithKline
Dr. Reddy's
Novartis
Valeant
Market Segment by Product Type
Acyclovir
Valacyclovir
Famciclovir
Market Segment by Application
HSV-1
HSV-2
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Genital Herpes Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Genital Herpes Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Genital Herpes Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Genital Herpes Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Acyclovir
- 1.3.3 Valacyclovir
- 1.3.4 Famciclovir
- 1.4 Market Segment by Application
- 1.4.1 Global Genital Herpes Treatment Market Share by Application (2019-2025)
- 1.4.2 HSV-1
- 1.4.3 HSV-2
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Genital Herpes Treatment Market Size
- 2.1.1 Global Genital Herpes Treatment Revenue 2014-2025
- 2.1.2 Global Genital Herpes Treatment Sales 2014-2025
- 2.2 Genital Herpes Treatment Growth Rate by Regions
- 2.2.1 Global Genital Herpes Treatment Sales by Regions 2014-2019
- 2.2.2 Global Genital Herpes Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Genital Herpes Treatment Sales by Manufacturers
- 3.1.1 Genital Herpes Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Genital Herpes Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Genital Herpes Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Genital Herpes Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Genital Herpes Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Genital Herpes Treatment Price by Manufacturers
- 3.4 Key Manufacturers Genital Herpes Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Genital Herpes Treatment Market
- 3.6 Key Manufacturers Genital Herpes Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Acyclovir Sales and Revenue (2014-2019)
- 4.1.2 Valacyclovir Sales and Revenue (2014-2019)
- 4.1.3 Famciclovir Sales and Revenue (2014-2019)
- 4.2 Global Genital Herpes Treatment Sales Market Share by Type
- 4.3 Global Genital Herpes Treatment Revenue Market Share by Type
- 4.4 Genital Herpes Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Genital Herpes Treatment Sales by Application
6 United States
- 6.1 United States Genital Herpes Treatment Breakdown Data by Company
- 6.2 United States Genital Herpes Treatment Breakdown Data by Type
- 6.3 United States Genital Herpes Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Genital Herpes Treatment Breakdown Data by Company
- 7.2 European Union Genital Herpes Treatment Breakdown Data by Type
- 7.3 European Union Genital Herpes Treatment Breakdown Data by Application
8 China
- 8.1 China Genital Herpes Treatment Breakdown Data by Company
- 8.2 China Genital Herpes Treatment Breakdown Data by Type
- 8.3 China Genital Herpes Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Genital Herpes Treatment Breakdown Data by Company
- 9.2 Rest of World Genital Herpes Treatment Breakdown Data by Type
- 9.3 Rest of World Genital Herpes Treatment Breakdown Data by Application
- 9.4 Rest of World Genital Herpes Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Genital Herpes Treatment Sales by Countries
- 9.4.2 Rest of World Genital Herpes Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Teva
- 10.1.1 Teva Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.1.4 Genital Herpes Treatment Product Introduction
- 10.1.5 Teva Recent Development
- 10.2 Abbott
- 10.2.1 Abbott Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.2.4 Genital Herpes Treatment Product Introduction
- 10.2.5 Abbott Recent Development
- 10.3 Sun
- 10.3.1 Sun Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.3.4 Genital Herpes Treatment Product Introduction
- 10.3.5 Sun Recent Development
- 10.4 Mylan
- 10.4.1 Mylan Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.4.4 Genital Herpes Treatment Product Introduction
- 10.4.5 Mylan Recent Development
- 10.5 Pfizer
- 10.5.1 Pfizer Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.5.4 Genital Herpes Treatment Product Introduction
- 10.5.5 Pfizer Recent Development
- 10.6 GlaxoSmithKline
- 10.6.1 GlaxoSmithKline Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.6.4 Genital Herpes Treatment Product Introduction
- 10.6.5 GlaxoSmithKline Recent Development
- 10.7 Dr. Reddy's
- 10.7.1 Dr. Reddy's Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.7.4 Genital Herpes Treatment Product Introduction
- 10.7.5 Dr. Reddy's Recent Development
- 10.8 Novartis
- 10.8.1 Novartis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.8.4 Genital Herpes Treatment Product Introduction
- 10.8.5 Novartis Recent Development
- 10.9 Valeant
- 10.9.1 Valeant Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Genital Herpes Treatment
- 10.9.4 Genital Herpes Treatment Product Introduction
- 10.9.5 Valeant Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Genital Herpes Treatment Sales Channels
- 11.2.2 Genital Herpes Treatment Distributors
- 11.3 Genital Herpes Treatment Customers
12 Market Forecast
- 12.1 Global Genital Herpes Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Genital Herpes Treatment Sales Forecast by Type
- 12.3 Global Genital Herpes Treatment Sales Forecast by Application
- 12.4 Genital Herpes Treatment Forecast by Regions
- 12.4.1 Global Genital Herpes Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Genital Herpes Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Genital Herpes Treatment. Industry analysis & Market Report on Genital Herpes Treatment is a syndicated market report, published as Global (United States, European Union and China) Genital Herpes Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Genital Herpes Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
